A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. - Herz,M.; Johns,D.; Reviriego,J.; Grossman,LD. (Clin Ther, 2003)